CD274 and cancer: To optimally set up a treatment regimen based on Galsome vaccination and PD-1/PD-L1 therapy and avoid unneeded administration of immune checkpoint inhibitors in combination with cancer vaccination, it is key to study the onset and dynamics of PD-L1 expression upon Galsome vaccination.